Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $14.2 million.

  • Ultralife's Accounts Payables rose 1169.47% to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year increase of 1169.47%. This contributed to the annual value of $14.2 million for FY2024, which is 2491.18% up from last year.
  • As of Q3 2025, Ultralife's Accounts Payables stood at $14.2 million, which was up 1169.47% from $15.0 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Accounts Payables ranged from a high of $19.0 million in Q1 2023 and a low of $9.2 million during Q3 2021
  • For the 4-year period, Ultralife's Accounts Payables averaged around $13.3 million, with its median value being $13.4 million (2023).
  • Its Accounts Payables has fluctuated over the past 5 years, first crashed by 4773.21% in 2024, then surged by 5508.2% in 2025.
  • Quarter analysis of 4 years shows Ultralife's Accounts Payables stood at $9.2 million in 2021, then increased by 23.14% to $11.3 million in 2023, then grew by 24.91% to $14.2 million in 2024, then rose by 0.03% to $14.2 million in 2025.
  • Its Accounts Payables stands at $14.2 million for Q3 2025, versus $15.0 million for Q2 2025 and $16.6 million for Q1 2025.